Kevin John Merchant
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kevin John Merchant.
Tetrahedron Letters | 2000
Kevin John Merchant
Abstract Treatment of nitriles with potassium trimethylsilanolate under mild anhydrous conditions readily yields the corresponding primary amides after a simple aqueous workup.
Bioorganic & Medicinal Chemistry Letters | 1993
Eileen Mary Seward; Christopher John Swain; Kevin John Merchant; Simon Neil Owen; Verity Margaret Sabin; Margaret A. Cascieri; Sharon Sadowski; Catherine D. Strader; Raymond Baker
Abstract A series of 3-benzyloxy-derivatives of CP-96,345 has been evaluated and found to have significant affinity for the human NK1 receptor. 3,5-Disubstitution of the benzyl ether has been identified to be essential for high affinity.
Bioorganic & Medicinal Chemistry Letters | 1998
Jason Matthew Elliott; Margaret A. Cascieri; Gary G. Chicchi; S. Davies; Fintan Kelleher; Marc M. Kurtz; Tammy Ladduwahetty; Richard Thomas Lewis; Angus Murray Macleod; Kevin John Merchant; Sharon Sadowski; Graeme Irvine Stevenson
A series of novel serine derived NK1 antagonists is described. The effect of variations in the N-benzyl, O-benzyl and serine groups are used to define the elements which are necessary for binding.
Bioorganic & Medicinal Chemistry Letters | 2010
Tammy Ladduwahetty; Myra Gilligan; Alexander Charles Humphries; Kevin John Merchant; Rebecca L. Fish; George McAlister; Magnus Ivarsson; María Domínguez; Desmond O’Connor; Angus Murray Macleod
Scaffold hopping from a non-basic series of 5-HT(2A) receptor antagonists developed in-house that possessed reduced activity in vivo enabled the discovery of a novel series of diaryl sulfones that gave excellent occupancy on oral dosing. Not only does this work further demonstrate that oral bioavailability of a given series can be enhanced by improving physicochemical parameters such as log P, but it corroborates the growing evidence that a protonated amine is not essential for affinity at aminergic GPCRs.
Tetrahedron Letters | 1994
Kevin John Merchant; Richard Thomas Lewis; Angus Murray Macleod
Abstract The synthesis in 36% overall yield of (S)-2-amino-5-(3,5-bis(trifluoromethyl)phenyl)-1-(3-indolyl-3-pentanone, the precursor to a novel class of substance P antagonists, is described.
Journal of The Chemical Society-perkin Transactions 1 | 1991
Roger J. Snow; Raymond Baker; Richard H. Herbert; Ian J. Hunt; Kevin John Merchant; John Saunders
Quinuclidine-3-carboxylic esters bearing 5-hydroxy, 5-methyl and 6-methyl substituents are of interest as precursors to novel muscarinic ligands. All diastereoisomers of these disubstituted quinuclidines have been prepared, in each case using an appropriately substituted quinuclidin-3-one as the key intermediate. The keto ester 5a was obtained stereoselectively, either by intramolecular alkylation of a bromoacetylpiperidine, or by Dieckmann cyclisation of the differentially protected piperidine 18. 5-Methylquinuclidin-3-one was formed as a single isomer 24b by Dieckmann cyclisation. Piperidine-2,4-diester 33, in contrast, yielded a mixture of 2,5-disubstituted quinuclidine isomers 34 on cyclisation. Elaboration of the quinuclidinones gave the required esters, in several cases with high stereoselectivity. The stereochemical outcome of the Dieckmann cyclisation has been rationalised on the basis of molecular mechanics calculations.
Archive | 1994
Richard Thomas Lewis; Kevin John Merchant; Angus Murray Macleod
Archive | 1987
Raymond Baker; Angus Murray Macleod; Kevin John Merchant; John Saunders
Archive | 1988
Raymond Baker; John Saunders; Angus Murray Macleod; Kevin John Merchant
Bioorganic & Medicinal Chemistry Letters | 2006
Alexander Charles Humphries; Emanuela Gancia; Myra Gilligan; Simon Charles Goodacre; David James Hallett; Kevin John Merchant; Steve Thomas